Serum proteinase inhibitor capacity during administration of the oral contraceptive Ovosiston
Duck, H.J.; Ebeling, K.; Wagner, J.; Kühndel, K.
Zentralblatt für Gynakologie 95(10): 343-348
1973
ISSN/ISBN: 0044-4197 PMID: 4121777 Document Number: 65189
Document emailed within 1 workday
Related Documents
Kühne, D. 1970: "1st experiences with Ovosiston in new dosage--a comparative study of oral contraception with 'old' and 'new' Ovosiston". "Experiences with Ovosiston in contraception. II. "Viewpoint concerning works of Chr. Zwahr and H. Geschke Das Deutsche Gesundheitswesen 25(47): 2245-2247Johnson, H.W.; Lee, G.B. 1971: Changes in serum lipids. During administration of an oral contraceptive Minnesota Medicine 54(5): 335-336
Arora, S.; Arora, R.C.; Garg, R.K.; Agarwal, N.; Nautiyal, A. 1988: Effect of administration and withdrawal of oral contraceptive pills on serum lipids and lipoproteins Indian Journal of Physiology and Pharmacology 32(1): 67-71
Kuhnz, W.; al-Yacoub, G.; Fuhrmeister, A. 1992: Pharmacokinetics of levonorgestrel and ethinylestradiol in 9 women who received a low-dose oral contraceptive over a treatment period of 3 months and, after a wash-out phase, a single oral administration of the same contraceptive formulation Contraception 46(5): 455-469
Ogloblina, O.G.; Platonova, L.V.; Paskhina, T.S. 1979: Inhibition of human granulocyte proteinases by a heat and acid-stable proteinase inhibitor from rabbit serum Biokhimiia 44(4): 672-683
Abdalla, K.A.; Shabaan, M.M.; Stanczyk, F.Z. 1992: Interrelationship of serum levonorgestrel and sex hormone-binding globulin levels following vaginal and oral administration of combined steroid contraceptive tablets Contraception 45(2): 111-118
Theron, A.J.; Anderson, R. 1988: Investigation of the effects of oral administration of ascorbate on the functional activity of serum alpha-1-protease inhibitor and oxidant release by blood phagocytes from cigarette smokers in a placebo-controlled, doubleblind, crossover trial International Journal for Vitamin and Nutrition Research. Internationale Zeitschrift für Vitamin- und Ernahrungsforschung. Journal International de Vitaminologie et de Nutrition 58(2): 218-224
Kalbag, J.; Elder, C.; Scott, G.; Wang, Y.; Milosavljev, S.; Leese, P.; Caldwell, J.; Rordorf, C. 2004: Concomitant administration of lumiracoxib and a triphasic oral contraceptive does not affect contraceptive activity or pharmacokinetic profile Journal of Clinical Pharmacology 44(6): 646-654
Li, X.F. Ye, B.L.; Wu, X.W.; Wu, Z.Y.; Kong, S.M.; Sang, G.W. 1988: Effects of long term use of oral contraceptives on serum prl and the response to oral administration of metoclopramide Advances in Contraception 4(1): 64-65
Isacco, L.; Thivel, D.; Pereira, B.; Duclos, M.; Boisseau, N. 2015: Maximal fat oxidation, but not aerobic capacity, is affected by oral contraceptive use in young healthy women European Journal of Applied Physiology 115(5): 937-945
Garg, V.; van Heeswijk, R.; Yang, Y.; Kauffman, R.; Smith, F.; Adda, N. 2012: The pharmacokinetic interaction between an oral contraceptive containing ethinyl estradiol and norethindrone and the HCV protease inhibitor telaprevir Journal of Clinical Pharmacology 52(10): 1574-1583
Friederich, P.W.; Keller, T.T.; Biemond, B.J.; Peters, R.J.; Hornberger, W.; Büller, H.R.; Levi, M. 2000: Successful attenuation of venous thrombus growth in rabbits after the administration of a novel oral thrombin inhibitor Thrombosis and Haemostasis 84(5): 858-864
Ogawa, T.; Kotani, S.; Shimauchi, H. 1986: Enhancement of serum antibody production in mice by oral administration of lipophilic derivatives of muramylpeptides and bacterial lipopolysaccharides with bovine serum albumin Methods and Findings in Experimental and Clinical Pharmacology 8(1): 19-26
Küçük, M.; Sezer, S.D.; Odabaşi, A.R.; Güner, Z.; Yuksel, H.; Serter, M. 2011: The effect of low-dose combined oral contraceptive containing 100 ug levonorgestrel on plasma plasminogen activator inhibitor-1 concentrations Clinical and Experimental Obstetrics and Gynecology 38(1): 54-56
Altschuler, S.L.; Valenteen, J.W. 1974: Amenorrhea following rifampin administration during oral contraceptive use Obstetrics and Gynecology 44(5): 771-772
Chen, J.; Bhansali, S.; Neelakantham, S.; Trusley, C.; Majumdar, T.; Rebello, S.; Sunkara, G.; Meyers, C. 2015: Effect of pradigastat, a diacylglycerol acyltransferase 1 inhibitor, on the pharmacokinetics of a combination oral contraceptive in healthy female subjects International Journal of Clinical Pharmacology and Therapeutics 53(4): 317-324
Lin, W.H.; Feng, H.-P.; Shadle, C.R.; O'Reilly, T.; Wagner, J.A.; Butterton, J.R. 2014: Pharmacokinetic and pharmacodynamic interactions between the hepatitis C virus protease inhibitor, boceprevir, and the oral contraceptive ethinyl estradiol/norethindrone European Journal of Clinical Pharmacology 70(9): 1107-1113
Hester, K.E.; Harper, M.J.K.; Duffy, D.M. 2010: Oral administration of the cyclooxygenase-2 (COX-2) inhibitor meloxicam blocks ovulation in non-human primates when administered to simulate emergency contraception Human Reproduction 25(2): 360-367
Friedman, M.; Zimmer, E.Z.; Graubard, Z.G. 1984: Mesenteric vein thrombosis associated with oral contraceptive administration during pregnancy Annales Chirurgiae et Gynaecologiae 73(5): 296-298
Olatunji, L.A.; Soladoye, A.O. 2010: Effects of chronic treatment with cyclooxygenase inhibitor, indomethacin on oral contraceptive-induced high blood pressure in female rats African Journal of Medicine and Medical Sciences 39(1): 21-27